Our project is designed to enhance global healthcare systems, support future research, and create an open-access knowledge base for the international community. Together, we are building a brighter future for diagnosing and treating complex mental disorders.
We revolutionize diagnostics with cutting-edge technology:
- Innovative Diagnostic Methods
- Artificial Intelligence
- European Collaboration
Schizophrenia affects approximately 80 million people worldwide, severely impacting the lives of patients and their families. VOLABIOS is dedicated to introducing innovative, costeffective tools that improve diagnostic accuracy by up to 30%, reduce diagnostic timelines, and enable timely interventions that can transform patient outcomes.
VOLABIOS is an innovative European research project aiming to revolutionize the early diagnosis of schizophrenia. By leveraging advanced technologies, such as Multi-Omics approaches, mobile spectrometry (volatolomics), and artificial intelligence, VOLABIOS is paving the way for groundbreaking solutions to detect and understand this complex mental health condition.